Methyltransferase-like 3–catalysed N6-methyladenosine methylation facilitates the contribution of vascular smooth muscle cells to atherosclerosis
Cardiovascular Research · 2025
DOI: 10.1093/cvr/cvaf029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2025. Verfasst von Zhigang Dong und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, 38 Xueyuan Road, Haidian District, Beijing 100191,…. Hauptthemen laut MEDLINE: Methyltransferases, Adenosine, Muscle, Smooth, Vascular, Atherosclerosis. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Science Foundation of China, Special Fund for Talents from Peking University.
Abstract (Originalsprache)
Aims
Vascular smooth muscle cells (VSMCs) are involved in the aetiology of atherosclerosis, but whether methyltransferase-like 3 (METTL3)–catalysed N6-methyladenosine (m6A) modulates the contribution of VSMCs to atherosclerosis remains elusive. Methods and results We generated tamoxifen-inducible VSMC-specific METTL3 knockout mice with VSMC lineage tracing and found that VSMC-specific METTL3 deficiency substantially attenuated atherosclerosis and reduced the proportion of VSMCs in plaques, due to the inhibition of VSMC atheroprone phenotype as characterized by macrophage-like and inflammatory features as well as high migratory and proliferative capacity. m6A-methylated RNA immunoprecipitation sequencing (MeRIP-Seq) combined with polysome profiling analysis mechanistically displayed METTL3-catalysed m6A methylation of myocardin-related transcription factor A (MRTFA) mRNA and further enhanced YTH N6-methyladenosine RNA-binding protein F3 (YTHDF3)–dependent MRTFA mRNA translation. Conversely, adenovirus or adeno-associated virus-mediated VSMC-specific MRTFA overexpression abolished METTL3 deficiency-mediated alleviation of VSMC atheroprone phenotypic switching and atherosclerotic progression both in vitro and in vivo.
Conclusion
METTL3 facilitated the contribution of VSMCs to atherosclerosis through the m6A-YTHDF3-dependent MRTFA mRNA translation enhancement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, 38 Xueyuan Road, Haidian District, Beijing 100191, China.
- State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, 38 Xueyuan Road, Haidian District, Beijing 100191, China.
- Department of Pathophysiology, School of Medicine, Jiangnan University, Wuxi 214122, China.
- Hwamei College of Life and Health Sciences, Zhejiang Wanli University, Ningbo 315100, China.
- Department of Vascular Surgery, Peking University People's Hospital, Peking University, Beijing 100191, China.
Förderung
- National Science Foundation of China
- Special Fund for Talents from Peking University
Zitieren
APA
Dong, Z., Jin, Y., Shen, Y., Huang, J., Tan, J., Feng, Q., Gong, Z., Zhu, S., Chen, H., Yu, F., Li, W., Jia, Y., Kong, W., & Fu, Y. (2025). Methyltransferase-like 3–catalysed N6-methyladenosine methylation facilitates the contribution of vascular smooth muscle cells to atherosclerosis. Cardiovascular Research. https://doi.org/10.1093/cvr/cvaf029
Vancouver
Dong Z, Jin Y, Shen Y, Huang J, Tan J, Feng Q, et al. Methyltransferase-like 3–catalysed N6-methyladenosine methylation facilitates the contribution of vascular smooth muscle cells to atherosclerosis. Cardiovascular Research. 2025. doi:10.1093/cvr/cvaf029
BibTeX
@article{Dong2025,
author = {Dong, Zhigang and Jin, Yourong and Shen, Yicong and Huang, Jiaqi and Tan, Jiaai and Feng, Qianqian and Gong, Ze and Zhu, Shirong and Chen, Huiyue and Yu, Fang and Li, Wei and Jia, Yiting and Kong, Wei and Fu, Yi},
title = {Methyltransferase-like 3–catalysed N6-methyladenosine methylation facilitates the contribution of vascular smooth muscle cells to atherosclerosis},
journal = {Cardiovascular Research},
year = {2025},
doi = {10.1093/cvr/cvaf029}
}
EUVIMED